Skip to main content
  • Main menu
  • User menu
  • Search

Main menu

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
PDA Journal of Pharmaceutical Science and Technology
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
PDA Journal of Pharmaceutical Science and Technology

Advanced Search

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • Follow pda on Twitter
  • Visit PDA on LinkedIn
  • Visit pda on Facebook
Research ArticleConference Report

Meeting Report: PDA Virus and TSE Safety Forum

Hannelore Willkommen, Johannes BlüMel, Kurt Brorson, Dayue Chen, Qi Chen, Albrecht GröNer, Thomas R. Kreil, James S. Robertson, Michel Ruffing and Sol Ruiz
PDA Journal of Pharmaceutical Science and Technology March 2013, 67 (2) 81-97; DOI: https://doi.org/10.5731/pdajpst.2013.00906
Hannelore Willkommen
aRegulatory Affairs & Biological Safety Consulting, Erzhausen, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: hannelore.willkommen@gmx.de
Johannes BlüMel
bPaul-Ehrlich Institut, Langen, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kurt Brorson
cCDER/FDA, Silver Spring MD, USA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dayue Chen
dEli Lilly and Company, Indianapolis, IN, USA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Qi Chen
eGenentech Inc., Genentech, Inc., South San Francisco, CA, USA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Albrecht GröNer
fCSL Behring GmbH, Marburg, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas R. Kreil
gBaxter BioScience, Vienna, Austria;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James S. Robertson
hNational Institute for Biological Standards and Control, Potters Bar, UK;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michel Ruffing
iBoehringer Ingelheim Pharma GmbH&KG, Bieberach an der Riss, Germany; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sol Ruiz
jSpanish Medicines Agency (AEMPS), Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • References
  • Info & Metrics
  • PDF
Loading

References

  1. 1.↵
    ICH Q5A (R1): Quality of biotechnological products: viral safety evaluation of biotechnology products derived from cell lines of human or animal origin. CPMP/ICH/295/95. October 1997. http://www.ema.europa.eu.
    Google Scholar
  2. 2.↵
    1. Victoria J. G.,
    2. Wang C.,
    3. Jones M. S.,
    4. Jaing C.,
    5. McLoughlin K.,
    6. Gardner S.,
    7. Delwart E. L.
    Viral nucleic acids in live-attenuated vaccines: detection of minority variants and an adventitious virus. J. Virol. 2010, 84 (12), 6033–6040.
    OpenUrlAbstract/FREE Full TextGoogle Scholar
  3. 3.↵
    EMA/CHMP/BWP/548524/2008: Guideline on epidemiological data on blood transmissible infection. 22 April 2010. http://www.ema.europa.eu.
    Google Scholar
  4. 4.↵
    1. Murphy M.,
    2. Quesada G. M.,
    3. Chen D.
    Effectiveness of mouse minute virus inactivation by high temperature short time treatment technology: a statistical assessment. Biologicals 2011, 39 (6): 438–443.
    OpenUrlPubMedGoogle Scholar
  5. 5.↵
    1. Onions D.,
    2. Kolman J.
    Massively parallel sequencing, a new method for detecting adventitious agents. Biologicals 2010, 38 (3), 377–380.
    OpenUrlPubMedGoogle Scholar
  6. 6.↵
    1. Sampath R.,
    2. Blyn L. B.,
    3. Ecker D. J.
    Rapid molecular assays for microbial contaminant monitoring in the bioprocess industry. PDA J. Pharm. Sci. Technol. 2010, 64 (5), 458–464.
    OpenUrlAbstract/FREE Full TextGoogle Scholar
  7. 7.↵
    1. C. R. Ill.,
    2. Dehghani H.
    Risk reduction in biotherapeutic products. Curr. Opin. Drug Discov. Devel. 2009, 12 (2), 296–304.
    OpenUrlPubMedGoogle Scholar
  8. 8.↵
    1. Lawrence B.,
    2. Bashiri H.,
    3. Dehghani H.
    Cross comparison of rapid mycoplasma detection platforms. Biologicals 2010, 38 (2), 218–223.
    OpenUrlPubMedGoogle Scholar
  9. 9.↵
    1. Lamson D.,
    2. Renwick N.,
    3. Kapoor V.,
    4. Liu Z.,
    5. Palacios G.,
    6. Ju J.,
    7. Dean A.,
    8. St. George K.,
    9. Briese T.,
    10. Lipkin W. I.
    MassTag polymerase-chain-reaction detection of respiratory pathogens, including a new rhinovirus genotype, that caused influenza-like illness in New York State during 2004–2005. J. Infect. Dis. 2006, 194 (10), 1398–1402.
    OpenUrlAbstract/FREE Full TextGoogle Scholar
  10. 10.↵
    1. Palacios G.,
    2. Quan P.-L.,
    3. Jabado O. J.,
    4. Conlan S.,
    5. Hirschberg D. L.,
    6. Liu Y.,
    7. Zhai J.,
    8. Renwick N.,
    9. Hui J.,
    10. Hegyi H.,
    11. Grolla A.,
    12. Strong J. E.,
    13. Towner J. S.,
    14. Geisbert T. W.,
    15. Jarhling P. B.,
    16. Büchen-Osmond C. V.,
    17. Ellerbrok H.,
    18. Sanchez-Seco M. P.,
    19. Lussier Y.,
    20. Formenty P.,
    21. Nichol S. T.,
    22. Feldmann H.,
    23. Briese T.,
    24. Lipkin W. I.
    Panmicrobial oligonucleotide array for diagnosis of infectious diseases. Emerg. Infect. Dis. 2007, 13 (1), 73–81.
    OpenUrlCrossRefPubMedWeb of ScienceGoogle Scholar
  11. 11.↵
    1. Briese T.,
    2. Paweska J. T.,
    3. McMullan L. K.,
    4. Hutchison S. K.,
    5. Street C.,
    6. Palacios G.,
    7. Khristova M. L.,
    8. Weyer J.,
    9. Swanepoel R.,
    10. Egholm M.,
    11. Nichol S. T.,
    12. Lipkin W. I.
    Genetic detection and characterization of Lujo virus, a new hemorrhagic fever-associated arenavirus from southern Africa. PLoS Pathog. 2009, 5 (5), e1000455.
    OpenUrlCrossRefPubMedGoogle Scholar
  12. 12.↵
    1. Quan P. L.,
    2. Wagner T. A.,
    3. Briese T.,
    4. Torgerson T. R.,
    5. Hornig M.,
    6. Tashmukhamedova A.,
    7. Firth C.,
    8. Palacios G.,
    9. Baisre-de-Leon A.,
    10. Paddock C. D.,
    11. Hutchison S. K.,
    12. Egholm M.,
    13. Zaki S. R.,
    14. Goldman J. E.,
    15. Ochs H. D.,
    16. Lipkin W. I.
    Astrovirus encephalitis in boy with X-linked agammaglobulinemia. Emerg. Infect. Dis. 2010, 16 (6): 918–925.
    OpenUrlCrossRefPubMedGoogle Scholar
  13. 13.↵
    1. Farcet M. R.,
    2. Kindermann J.,
    3. Modrof J.,
    4. Kreil T. R.
    Inactivation of hepatitis A variants during heat treatment (pasteurization) of human serum albumin. Transfusion 2012, 52 (1), 181–187.
    OpenUrlGoogle Scholar
  14. 14.↵
    1. Miesegaes G.,
    2. Bailey M.,
    3. Willkommen H.,
    4. Chen Q.,
    5. Roush D.,
    6. Blümel J.,
    7. Brorson K.
    Proceedings of the 2009 viral clearance symposium. Dev. Biol. 2011, 113, 3–104.
    OpenUrlGoogle Scholar
  15. 15.↵
    1. Dichtelmuller H. O.,
    2. Biesert L.,
    3. Fabrizzi F.,
    4. Gajardo R.,
    5. Groner H.,
    6. Jorquera J. I.,
    7. Kempf C.,
    8. Kreil T. R.,
    9. Pifat W.,
    10. Osheroff W.,
    11. Poelsler G.
    Robustness of solvent/detergent treatment of plasma derivatives: a data collection from Plasma Protein Therapeutics Association member companies. Transfusion 2009, 49 (9), 1931–1943.
    OpenUrlCrossRefGoogle Scholar
  16. 16.↵
    EMEA/CHMP/BWP/398498/2005: Guideline on virus safety evaluation of biotechnological investigational medicinal products. 1 February 2009. http://www.ema.europa.eu.
    Google Scholar
  17. 17.↵
    OIE-World Organization of Animal Health: Bovine Spongiform Encephalopathy Status of Members according to Resolution No. 17, May 2011, http://www.oie.int/animal-health-in-the-world/official-disease-status/bse/list-of-bse-risk-status/.
    Google Scholar
  18. 18.↵
    National Blood Service: Transfusion Medicine Epidemiologial Review (TMER). http://www.cjd.ed.ac.uk/TMER/TMER.htm.
    Google Scholar
  19. 19.↵
    1. Peden A.,
    2. McCardle L.,
    3. Head M. W.,
    4. Love S.,
    5. Ward H. J. T.,
    6. Cousens S. N.,
    7. Keeling D. M.,
    8. Millar C. M.,
    9. Hill F. G. H.,
    10. Ironside J. W.
    Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia. Haemophilia 2010, 16 (2), 296–304.
    OpenUrlCrossRefPubMedWeb of ScienceGoogle Scholar
  20. 20.↵
    1. Puopolo M.,
    2. Ladogana A.,
    3. Vetrugno V.,
    4. Pocchiari M.
    Transmission of sporadic Creutzfeldt-Jakob disease by blood transfusion: risk factor or possible biases. Transfusion 2011, 51 (7), 1556–1566.
    OpenUrlCrossRefGoogle Scholar
  21. 21.↵
    European Commission: Note for guidance on minimizing the risk of transmitting animal spongiform encephalopathy agents via human and veterinary medicinal products (EMA/410/01 rev. 3). OJ C73, 5.3.2011, pp 1–18.
    Google Scholar
  22. 22.↵
    OIE: Terrestrial Animal Health Code, Chapter 11.5.: bovine spongiform encephalopathy. http://www.oie.int/index.php?id=169&L=0&htmfile=chapitre_1.11.5.htm.
    Google Scholar
  23. 23.↵
    EMA/CHMP/BWP/303353/2010: CHMP position statement on Creutzfeldt-Jakob disease and plasma-derived and urine-derived medicinal products. 23 June 2011. http://www.ema.europa.eu.
    Google Scholar
  24. 24.↵
    1. Hilton D. A.,
    2. Ghani A. C.,
    3. Conyers L.,
    4. Edwards P.,
    5. McCardle L.,
    6. Ritchie D.,
    7. Penney M.,
    8. Hegazy D.,
    9. Ironside J. W.
    Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J. Pathol. 2004, 203 (3), 733–739.
    OpenUrlCrossRefPubMedWeb of ScienceGoogle Scholar
  25. 25.↵
    1. de Marco M. F.,
    2. Linehan J.,
    3. Gill O. N.,
    4. Clewley J. P.,
    5. Brandner S.
    Large-scale immunohistochemical examination for lymphoreticular prion protein in tonsil specimens collected in Britain. J. Pathol. 2010, 222 (4), 380–387.
    OpenUrlCrossRefPubMedWeb of ScienceGoogle Scholar
  26. 26.↵
    1. Gregori L.,
    2. Kovacs G. G.,
    3. Alexeeva I.,
    4. Budka H.,
    5. Rohwer R. G.
    Excretion of transmissible spongiform encephalopathy infectivity in urine. Emerg. Infect. Dis. 2008, 14 (9), 1406–1412.
    OpenUrlCrossRefPubMedGoogle Scholar
  27. 27.↵
    1. Edgeworth J. A.,
    2. Farmer M.,
    3. Sicilia A.,
    4. Tavares P.,
    5. Beck J.,
    6. Campbell T.,
    7. Lowe J.,
    8. Mead S.,
    9. Rudge P.,
    10. Collinge J.,
    11. Jackson G. S.
    Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood based assay. Lancet 2011, 377 (9764), 487–493.
    OpenUrlCrossRefPubMedWeb of ScienceGoogle Scholar
  28. 28.↵
    1. Wilham J. M.,
    2. Orrú C. D.,
    3. Bessen R. A.,
    4. Atarashi R.,
    5. Sano K.,
    6. Race B.,
    7. Meade-White K. D.,
    8. Taubner L. M.,
    9. Timmes A.,
    10. Caughey B.
    Rapid end-point quantitation of prion seeding activity with sensitivity comparable to bioassays. PLoS Pathog. 2010, 6 (12), e1001217, doi:10.1371/journal.ppat.1001217.
    OpenUrlCrossRefPubMedGoogle Scholar
  29. 29.↵
    1. Pritzkow S.,
    2. Wagenführ K.,
    3. Daus M. L.,
    4. Boerner S.,
    5. Lemmer K.,
    6. Thomzig A.,
    7. Mielke M.,
    8. Beekes M.
    Quantitative detection and biological propagation of scrapie seeding activity in vitro facilitate use of prions as model pathogens for disinfection. PLoS One 2011, 6 (5), e20384, doi:10.1371/journal.pone.0020384.
    OpenUrlCrossRefPubMedGoogle Scholar
  30. 30.↵
    1. Thyer J.,
    2. Unal A.,
    3. Hartel G.,
    4. Middleton D.,
    5. Bingham J.,
    6. Braun M.,
    7. Uren E.,
    8. Maher D.
    Investigation of prion removal/inactivation from chromatographic gel. Vox Sang. 2006, 91 (4), 301–308.
    OpenUrlPubMedGoogle Scholar
  31. 31.↵
    CPMP/BWP/5136/03: Guideline on the investigation of manufacturing processes for plasma-derived medicinal products with regards to vCJD. 21 October 2004. http://www.ema.europa.eu.
    Google Scholar
  32. 32.↵
    1. Yunoki M.,
    2. Tanaka H.,
    3. Urayama T.,
    4. Hattori S.,
    5. Ohtani M.,
    6. Ohkubo Y.,
    7. Kawabata Y.,
    8. Miyatake Y.,
    9. Nanjo A.,
    10. Iwao E.,
    11. Morita M.,
    12. Wilson E.,
    13. MacLean C.,
    14. Ikuta K.
    Prion removal by nanofiltration under different experimental conditions. Biologicals 2008, 36 (1), 27–36.
    OpenUrlPubMedGoogle Scholar
  33. 33.↵
    1. Safar J. G.,
    2. Geschwind M. D.,
    3. Deering C.,
    4. Didorenko S.,
    5. Sattavat M.,
    6. Sanchez H.,
    7. Serban A.,
    8. Vey M.,
    9. Baron H.,
    10. Giles K.,
    11. Miller B. L.,
    12. DeArmond S. J.
    Diagnosis of human prion disease. Proc. Natl. Acad. Sci. 2005, 102 (9), 3501–3506.
    OpenUrlAbstract/FREE Full TextGoogle Scholar
PreviousNext
Back to top

In This Issue

PDA Journal of Pharmaceutical Science and Technology: 67 (2)
PDA Journal of Pharmaceutical Science and Technology
Vol. 67, Issue 2
March/April 2013
  • Table of Contents
  • Index by Author
Print
Download PDF
Article Alerts
Email Article
Citation Tools
Share
Meeting Report: PDA Virus and TSE Safety Forum
Hannelore Willkommen, Johannes BlüMel, Kurt Brorson, Dayue Chen, Qi Chen, Albrecht GröNer, Thomas R. Kreil, James S. Robertson, Michel Ruffing, Sol Ruiz
PDA Journal of Pharmaceutical Science and Technology Mar 2013, 67 (2) 81-97; DOI: 10.5731/pdajpst.2013.00906
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget

Jump to section

  • Article
    • Abstract
    • 1. Introduction
    • 2. Virus Safety Forum
    • 3. TSE Safety Forum
    • 4. Conclusions and Next Steps
    • Conflict of Interest Declaration
    • Acknowledgements
    • References
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Session 4: Overall Integrated Viral Clearance and Adventitious Agents Strategy
  • Use of MMV as a Single Worst-Case Model Virus in Viral Filter Validation Studies
  • Google Scholar

More in this TOC Section

  • Summary of the EMA Joint Regulators/Industry QbD workshop (London, UK; 28–29 January 2014)
  • Meeting Report: 2015 PDA Virus & TSE Safety Forum
  • PDA Single-Use Systems Cross-Organizational Workshop—Meeting Summary, May 14, 2014—PDA Global Headquarters, Bethesda, MD
Show more Conference Report

Similar Articles

Keywords

  • Virus
  • TSE
  • Safety
  • Biotechnology
  • Plasma derivatives
  • Regulatory affairs
  • Virus Clearance

Readers

  • About
  • Table of Content Alerts/Other Alerts
  • Subscriptions
  • Terms of Use
  • Contact Editors

Author/Reviewer Information

  • Author Resources
  • Submit Manuscript
  • Reviewers
  • Contact Editors

Parenteral Drug Association, Inc.

  • About
  • Advertising/Sponsorships
  • Events
  • PDA Bookstore
  • Press Releases

© 2025 PDA Journal of Pharmaceutical Science and Technology Print ISSN: 1079-7440  Digital ISSN: 1948-2124

Powered by HighWire
Alerts for this Article
Sign In to Email Alerts with your Email Address
Email this Article

Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Meeting Report: PDA Virus and TSE Safety Forum
(Your Name) has sent you a message from PDA Journal of Pharmaceutical Science and Technology
(Your Name) thought you would like to see the PDA Journal of Pharmaceutical Science and Technology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
12 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Meeting Report: PDA Virus and TSE Safety Forum
Hannelore Willkommen, Johannes BlüMel, Kurt Brorson, Dayue Chen, Qi Chen, Albrecht GröNer, Thomas R. Kreil, James S. Robertson, Michel Ruffing, Sol Ruiz
PDA Journal of Pharmaceutical Science and Technology Mar 2013, 67 (2) 81-97; DOI: 10.5731/pdajpst.2013.00906

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

We use cookies on this site to enhance your user experience

By clicking any link on this page you are giving your consent for us to set cookies.